These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 35736133)

  • 1. Therapeutic Inhibition of Staphylococcus aureus ArlRS Two-Component Regulatory System Blocks Virulence.
    Kwiecinski JM; Jelani DA; Fuentes EJ; Horswill AR
    Antimicrob Agents Chemother; 2022 Jul; 66(7):e0018722. PubMed ID: 35736133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Staphylococcus aureus Global Regulator MgrA Modulates Clumping and Virulence by Controlling Surface Protein Expression.
    Crosby HA; Schlievert PM; Merriman JA; King JM; Salgado-Pabón W; Horswill AR
    PLoS Pathog; 2016 May; 12(5):e1005604. PubMed ID: 27144398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disruption of Glycolysis by Nutritional Immunity Activates a Two-Component System That Coordinates a Metabolic and Antihost Response by Staphylococcus aureus.
    Párraga Solórzano PK; Yao J; Rock CO; Kehl-Fie TE
    mBio; 2019 Aug; 10(4):. PubMed ID: 31387906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A structure activity relationship study of 3,4'-dimethoxyflavone for ArlRS inhibition in
    Weig AW; O'Conner PM; Kwiecinski JM; Marciano OM; Nunag A; Gutierrez AT; Melander RJ; Horswill AR; Melander C
    Org Biomol Chem; 2023 Apr; 21(16):3373-3380. PubMed ID: 37013457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of ArlRS in regulating oxacillin susceptibility in methicillin-resistant Staphylococcus aureus indicates it is a potential target for antimicrobial resistance breakers.
    Bai J; Zhu X; Zhao K; Yan Y; Xu T; Wang J; Zheng J; Huang W; Shi L; Shang Y; Lv Z; Wang X; Wu Y; Qu D
    Emerg Microbes Infect; 2019; 8(1):503-515. PubMed ID: 30924407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Staphylococcus aureus adhesion in endovascular infections is controlled by the ArlRS-MgrA signaling cascade.
    Kwiecinski JM; Crosby HA; Valotteau C; Hippensteel JA; Nayak MK; Chauhan AK; Schmidt EP; Dufrêne YF; Horswill AR
    PLoS Pathog; 2019 May; 15(5):e1007800. PubMed ID: 31116795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Staphylococcus aureus ArlRS two-component system regulates virulence factor expression through MgrA.
    Crosby HA; Tiwari N; Kwiecinski JM; Xu Z; Dykstra A; Jenul C; Fuentes EJ; Horswill AR
    Mol Microbiol; 2020 Jan; 113(1):103-122. PubMed ID: 31618469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The FDA-approved anti-cancer drugs, streptozotocin and floxuridine, reduce the virulence of Staphylococcus aureus.
    Yeo WS; Arya R; Kim KK; Jeong H; Cho KH; Bae T
    Sci Rep; 2018 Feb; 8(1):2521. PubMed ID: 29410445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Sensor Histidine Kinase ArlS Is Necessary for Staphylococcus aureus To Activate ArlR in Response to Nutrient Availability.
    Párraga Solórzano PK; Shupe AC; Kehl-Fie TE
    J Bacteriol; 2021 Nov; 203(24):e0042221. PubMed ID: 34606376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of ArlRS in autolysis in methicillin-sensitive and methicillin-resistant Staphylococcus aureus strains.
    Memmi G; Nair DR; Cheung A
    J Bacteriol; 2012 Feb; 194(4):759-67. PubMed ID: 22139508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quercetin Reduces the Virulence of S. aureus by Targeting ClpP to Protect Mice from MRSA-Induced Lethal Pneumonia.
    Jing S; Kong X; Wang L; Wang H; Feng J; Wei L; Meng Y; Liu C; Chang X; Qu Y; Guan J; Yang H; Zhang C; Zhao Y; Song W
    Microbiol Spectr; 2022 Apr; 10(2):e0234021. PubMed ID: 35319277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Norwogonin aids in fighting MRSA-induced pneumonia by targeting agrA
    Liu C; Hou J; Ren X; Guo X; Wang B; Song W; Wang L; Wang G
    World J Microbiol Biotechnol; 2024 Jul; 40(9):265. PubMed ID: 38990361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. VraSR and Virulence Trait Modulation during Daptomycin Resistance in Methicillin-Resistant
    Taglialegna A; Varela MC; Rosato RR; Rosato AE
    mSphere; 2019 Feb; 4(1):. PubMed ID: 30760612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sub-Inhibitory Concentrations of Oxacillin, but Not Clindamycin, Linezolid, or Tigecycline, Decrease Staphylococcal Phenol-Soluble Modulin Expression in Community-Acquired Methicillin-Resistant Staphylococcus aureus.
    Hodille E; Beraud L; Périan S; Berti V; Bes M; Tristan A; Blond E; Lina G; Dumitrescu O
    Microbiol Spectr; 2022 Feb; 10(1):e0080821. PubMed ID: 35044221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Baicalin suppress growth and virulence-related factors of methicillin-resistant Staphylococcus aureus in vitro and vivo.
    Zhang S; Hu B; Xu J; Ren Q; Wang Z; Wang S; Dong Y; Yang G
    Microb Pathog; 2020 Feb; 139():103899. PubMed ID: 31790797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Two-Component System ArlRS and Alterations in Metabolism Enable Staphylococcus aureus to Resist Calprotectin-Induced Manganese Starvation.
    Radin JN; Kelliher JL; Párraga Solórzano PK; Kehl-Fie TE
    PLoS Pathog; 2016 Nov; 12(11):e1006040. PubMed ID: 27902777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of an antivirulence agent targeting the master regulator of virulence genes in
    Arya R; Kim T; Youn JW; Bae T; Kim KK
    Front Cell Infect Microbiol; 2023; 13():1268044. PubMed ID: 38029271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dehydrosqualene Desaturase as a Novel Target for Anti-Virulence Therapy against
    Gao P; Davies J; Kao RYT
    mBio; 2017 Sep; 8(5):. PubMed ID: 28874472
    [No Abstract]   [Full Text] [Related]  

  • 19. Redeploying β-Lactam Antibiotics as a Novel Antivirulence Strategy for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections.
    Waters EM; Rudkin JK; Coughlan S; Clair GC; Adkins JN; Gore S; Xia G; Black NS; Downing T; O'Neill E; Kadioglu A; O'Gara JP
    J Infect Dis; 2017 Jan; 215(1):80-87. PubMed ID: 28077586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hesperidin inhibits biofilm formation, virulence and staphyloxanthin synthesis in methicillin resistant Staphylococcus aureus by targeting SarA and CrtM: an in vitro and in silico approach.
    Vijayakumar K; Muhilvannan S; Arun Vignesh M
    World J Microbiol Biotechnol; 2022 Jan; 38(3):44. PubMed ID: 35064842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.